This page is part of the FHIR Specification (v1.8.0: STU 3 Draft). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3
FHIR Value set/code system definition for HL7 v2 table 0227 ( Manufacturers of Vaccines (code=MVX))
<CodeSystem xmlns="http://hl7.org/fhir"> <id value="v2-0227"/> <meta> <profile value="http://hl7.org/fhir/StructureDefinition/codesystem-shareable-definition"/> </meta> <text> <status value="additional"/> <div xmlns="http://www.w3.org/1999/xhtml"> <p>Manufacturers of Vaccines (code=MVX)</p> <table class="grid"> <tr> <td> <b>Code</b> </td> <td> <b>Description</b> </td> <td> <b>Nederlands (Dutch)</b> </td> <td> <b>Comment</b> </td> <td> <b>Version</b> </td> </tr> <tr> <td>AB <a name="AB"> </a> </td> <td>Abbott Laboratories</td> <td>Abbott Laboratories</td> <td>(includes Ross Products Division)</td> <td>added v2.3</td> </tr> <tr> <td>AD <a name="AD"> </a> </td> <td>Adams Laboratories, Inc.</td> <td>Adams Laboratories, Inc.</td> <td/> <td>added v2.3</td> </tr> <tr> <td>ALP <a name="ALP"> </a> </td> <td>Alpha Therapeutic Corporation</td> <td>Alpha Therapeutic Corporation</td> <td/> <td>added v2.3</td> </tr> <tr> <td>AR <a name="AR"> </a> </td> <td>Armour</td> <td>Armour</td> <td>[Inactive--use AVB]</td> <td>added v2.3</td> </tr> <tr> <td>AVB <a name="AVB"> </a> </td> <td>Aventis Behring L.L.C.</td> <td>Aventis Behring L.L.C.</td> <td>(formerly Centeon L.L.C.; includes Armour Pharmaceutical Company) [Inactive--use ZLB] CDC Changes made on: Feb. 28, 2006</td> <td>added v2.5</td> </tr> <tr> <td>AVI <a name="AVI"> </a> </td> <td>Aviron</td> <td>Aviron</td> <td/> <td>added v2.3.1</td> </tr> <tr> <td>BA <a name="BA"> </a> </td> <td>Baxter Healthcare Corporation</td> <td>Baxter Healthcare Corporation</td> <td>[Inactive--use BAH]</td> <td>added v2.3</td> </tr> <tr> <td>BAH <a name="BAH"> </a> </td> <td>Baxter Healthcare Corporation</td> <td>Baxter Healthcare Corporation</td> <td>(includes Hyland Immuno, Immuno International AG, and North American Vaccine, Inc.)</td> <td>added v2.5</td> </tr> <tr> <td>BAY <a name="BAY"> </a> </td> <td>Bayer Corporation</td> <td>Bayer Corporation</td> <td>(includes Miles, Inc. and Cutter Laboratories)</td> <td>added v2.3</td> </tr> <tr> <td>BP <a name="BP"> </a> </td> <td>Berna Products</td> <td>Berna Products</td> <td>[Inactive--use BPC]</td> <td>added v2.3</td> </tr> <tr> <td>BPC <a name="BPC"> </a> </td> <td>Berna Products Corporation</td> <td>Berna Products Corporation</td> <td>(includes Swiss Serum and Vaccine Institute Berne)</td> <td>added v2.3.1</td> </tr> <tr> <td>CEN <a name="CEN"> </a> </td> <td>Centeon L.L.C.</td> <td>Centeon L.L.C.</td> <td>[Inactive--use AVB]</td> <td>added v2.3.1</td> </tr> <tr> <td>CHI <a name="CHI"> </a> </td> <td>Chiron Corporation</td> <td>Chiron Corporation</td> <td>[Inactive--use NOV] includes PowderJect Pharmaceuticals, Celltech Medeva Vaccines and Evans Medical Limited CDC Changes made on: July 14, 2006</td> <td>added v2.3.1</td> </tr> <tr> <td>CMP <a name="CMP"> </a> </td> <td>Celltech Medeva Pharmaceuticals</td> <td>Celltech Medeva Pharmaceuticals</td> <td>[Inactive--use NOV] CDC Changes made on: July 14, 2006</td> <td>added v2.5</td> </tr> <tr> <td>CNJ <a name="CNJ"> </a> </td> <td>Cangene Corporation</td> <td>Cangene Corporation</td> <td>CDC Changes made on: Feb. 28, 2006</td> <td>added v2.6</td> </tr> <tr> <td>CON <a name="CON"> </a> </td> <td>Connaught</td> <td>Connaught</td> <td>[Inactive--use PMC]</td> <td>added v2.3</td> </tr> <tr> <td>DVC <a name="DVC"> </a> </td> <td>DynPort Vaccine Company, LLC</td> <td>DynPort Vaccine Company, LLC</td> <td>CDC Changes made on: July 14, 2006</td> <td>added v2.6</td> </tr> <tr> <td>EVN <a name="EVN"> </a> </td> <td>Evans Medical Limited</td> <td>Evans Medical Limited</td> <td>[Inactive--use NOV] CDC Changes made on: July 14, 2006</td> <td>added v2.3</td> </tr> <tr> <td>GEO <a name="GEO"> </a> </td> <td>GeoVax Labs, Inc.</td> <td>GeoVax Labs, Inc.</td> <td>CDC Changes made on: July 14, 2006</td> <td>added v2.6</td> </tr> <tr> <td>GRE <a name="GRE"> </a> </td> <td>Greer Laboratories, Inc.</td> <td>Greer Laboratories, Inc.</td> <td/> <td>added v2.3</td> </tr> <tr> <td>IAG <a name="IAG"> </a> </td> <td>Immuno International AG</td> <td>Immuno International AG</td> <td>[Inactive--use BAH]</td> <td>added v2.3.1</td> </tr> <tr> <td>IM <a name="IM"> </a> </td> <td>Merieux</td> <td>Merieux</td> <td>[Inactive--use PMC]</td> <td>added v2.3</td> </tr> <tr> <td>IUS <a name="IUS"> </a> </td> <td>Immuno-U.S., Inc.</td> <td>Immuno-U.S., Inc.</td> <td/> <td>added v2.3</td> </tr> <tr> <td>JPN <a name="JPN"> </a> </td> <td>The Research Foundation for Microbial Diseases of Osaka University</td> <td>The Research Foundation for Microbial Diseases of Osaka University</td> <td>(BIKEN)</td> <td>added v2.3</td> </tr> <tr> <td>KGC <a name="KGC"> </a> </td> <td>Korea Green Cross Corporation</td> <td>Korea Green Cross Corporation</td> <td/> <td>added v2.3</td> </tr> <tr> <td>LED <a name="LED"> </a> </td> <td>Lederle</td> <td>Lederle</td> <td>[Inactive--use WAL]</td> <td>added v2.3</td> </tr> <tr> <td>MA <a name="MA"> </a> </td> <td>Massachusetts Public Health Biologic Laboratories</td> <td>Massachusetts Public Health Biologic Laboratories</td> <td>[Inactive--use MBL]</td> <td>added v2.3</td> </tr> <tr> <td>MBL <a name="MBL"> </a> </td> <td>Massachusetts Biologic Laboratories</td> <td>Massachusetts Biologic Laboratories</td> <td>(formerly Massachusetts Public Health Biologic Laboratories)</td> <td>added v2.5</td> </tr> <tr> <td>MED <a name="MED"> </a> </td> <td>MedImmune, Inc.</td> <td>MedImmune, Inc.</td> <td/> <td>added v2.3.1</td> </tr> <tr> <td>MIL <a name="MIL"> </a> </td> <td>Miles</td> <td>Miles</td> <td>[Inactive--use BAY]</td> <td>added v2.3</td> </tr> <tr> <td>MIP <a name="MIP"> </a> </td> <td>Bioport Corporation</td> <td>Bioport Corporation</td> <td>(formerly Michigan Biologic Products Institute)</td> <td>added v2.3</td> </tr> <tr> <td>MSD <a name="MSD"> </a> </td> <td>Merck & Co., Inc.</td> <td>Merck & Co., Inc.</td> <td/> <td>added v2.3</td> </tr> <tr> <td>NAB <a name="NAB"> </a> </td> <td>NABI</td> <td>NABI</td> <td>(formerly North American Biologicals, Inc.)</td> <td>added v2.3</td> </tr> <tr> <td>NAV <a name="NAV"> </a> </td> <td>North American Vaccine, Inc.</td> <td>North American Vaccine, Inc.</td> <td>[Inactive--use BAH]</td> <td>added v2.3.1</td> </tr> <tr> <td>NOV <a name="NOV"> </a> </td> <td>Novartis Pharmaceutical Corporation</td> <td>Novartis Pharmaceutical Corporation</td> <td>(includes Chiron, PowderJect Pharmaceuticals, Celltech Medeva Vaccines and Evans Limited, Ciba-Geigy Limited and Sandoz Limited)</td> <td>added v2.3.1</td> </tr> <tr> <td>NVX <a name="NVX"> </a> </td> <td>Novavax, Inc.</td> <td>Novavax, Inc.</td> <td>CDC Changes made on: July 14, 2006</td> <td>added v2.6</td> </tr> <tr> <td>NYB <a name="NYB"> </a> </td> <td>New York Blood Center</td> <td>New York Blood Center</td> <td/> <td>added v2.3</td> </tr> <tr> <td>ORT <a name="ORT"> </a> </td> <td>Ortho-Clinical Diagnostics</td> <td>Ortho-Clinical Diagnostics</td> <td>(formerly Ortho Diagnostic Systems, Inc.)</td> <td>added v2.3.1</td> </tr> <tr> <td>OTC <a name="OTC"> </a> </td> <td>Organon Teknika Corporation</td> <td>Organon Teknika Corporation</td> <td/> <td>added v2.3</td> </tr> <tr> <td>OTH <a name="OTH"> </a> </td> <td>Other manufacturer</td> <td>Andere fabrikant</td> <td/> <td>added v2.3</td> </tr> <tr> <td>PD <a name="PD"> </a> </td> <td>Parkedale Pharmaceuticals</td> <td>Parkedale Pharmaceuticals</td> <td>(formerly Parke-Davis)</td> <td>added v2.3</td> </tr> <tr> <td>PMC <a name="PMC"> </a> </td> <td>sanofi pasteur</td> <td>sanofi pasteur</td> <td>(formerly Aventis Pasteur, Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux) CDC Changes made on: Feb. 28, 2006</td> <td>added v2.3.1</td> </tr> <tr> <td>PRX <a name="PRX"> </a> </td> <td>Praxis Biologics</td> <td>Praxis Biologics</td> <td>[Inactive--use WAL]</td> <td>added v2.3</td> </tr> <tr> <td>PWJ <a name="PWJ"> </a> </td> <td>PowderJect Pharmaceuticals</td> <td>PowderJect Pharmaceuticals</td> <td>(includes Celltech Medeva Vaccines and Evans Medical Limited) [Inactive--use NOV] CDC Changes made on: July 14, 2006</td> <td>added v2.5</td> </tr> <tr> <td>SCL <a name="SCL"> </a> </td> <td>Sclavo, Inc.</td> <td>Sclavo, Inc.</td> <td/> <td>added v2.3</td> </tr> <tr> <td>SI <a name="SI"> </a> </td> <td>Swiss Serum and Vaccine Inst.</td> <td>Swiss Serum and Vaccine Inst.</td> <td>[Inactive--use BPC]</td> <td>added v2.3</td> </tr> <tr> <td>SKB <a name="SKB"> </a> </td> <td>GlaxoSmithKline</td> <td>GlaxoSmithKline</td> <td>(formerly SmithKline Beecham; includes SmithKline Beecham and Glaxo Welcome)</td> <td>added v2.3</td> </tr> <tr> <td>SOL <a name="SOL"> </a> </td> <td>Solvay Pharmaceuticals</td> <td>Solvay, Pharmaceuticals</td> <td>CDC Changes made on: July 14, 2006</td> <td>added v2.6</td> </tr> <tr> <td>TAL <a name="TAL"> </a> </td> <td>Talecris Biotherapeutics</td> <td>Talecris Biotherapeutics</td> <td>(includes Bayer Biologicals) CDC Changes made on: Feb. 28, 2006</td> <td>added v2.6</td> </tr> <tr> <td>UNK <a name="UNK"> </a> </td> <td>Unknown manufacturer</td> <td>Unknown manufacturer</td> <td/> <td>added v2.3</td> </tr> <tr> <td>USA <a name="USA"> </a> </td> <td>United States Army Medical Research and Material Command</td> <td>United States Army Medical Research and Material Command</td> <td/> <td>added v2.3.1</td> </tr> <tr> <td>VXG <a name="VXG"> </a> </td> <td>VaxGen</td> <td>VaxGen</td> <td>CDC Changes made on: July 14, 2006</td> <td>added v2.6</td> </tr> <tr> <td>WA <a name="WA"> </a> </td> <td>Wyeth-Ayerst</td> <td>Wyeth-Ayerst</td> <td>[Inactive--use WAL]</td> <td>added v2.3</td> </tr> <tr> <td>WAL <a name="WAL"> </a> </td> <td>Wyeth-Ayerst</td> <td>Wyeth-Ayerst</td> <td>(includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics)</td> <td>added v2.3.1</td> </tr> <tr> <td>ZLB <a name="ZLB"> </a> </td> <td>ZLB Behring</td> <td>ZLB Behring</td> <td>(includes Aventis Behring and Armour Pharmaceutical Company) CDC Changes made on: Feb. 28, 2006</td> <td>added v2.6</td> </tr> </table> </div> </text> <url value="http://hl7.org/fhir/v2/0227"/> <identifier> <system value="urn:ietf:rfc:3986"/> <value value="urn:oid:2.16.840.1.133883.18.127"/> </identifier> <version value="2.8.2"/> <name value="v2 Manufacturers of Vaccines (code=MVX)"/> <status value="active"/> <experimental value="true"/> <publisher value="HL7, Inc"/> <contact> <telecom> <system value="url"/> <value value="http://hl7.org"/> </telecom> </contact> <description value="FHIR Value set/code system definition for HL7 v2 table 0227 ( Manufacturers of Vaccines (code=MVX))"/> <caseSensitive value="false"/> <valueSet value="http://hl7.org/fhir/ValueSet/v2-0227"/> <content value="complete"/> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="(includes Ross Products Division)"/> </extension> <code value="AB"/> <display value="Abbott Laboratories"/> <designation> <language value="nl"/> <value value="Abbott Laboratories"/> </designation> </concept> <concept> <code value="AD"/> <display value="Adams Laboratories, Inc."/> <designation> <language value="nl"/> <value value="Adams Laboratories, Inc."/> </designation> </concept> <concept> <code value="ALP"/> <display value="Alpha Therapeutic Corporation"/> <designation> <language value="nl"/> <value value="Alpha Therapeutic Corporation"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="[Inactive--use AVB]"/> </extension> <code value="AR"/> <display value="Armour"/> <designation> <language value="nl"/> <value value="Armour"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="(formerly Centeon L.L.C.; includes Armour Pharmaceutical Company) [Inactive--use ZLB] CDC Changes made on: Feb. 28, 2006"/> </extension> <code value="AVB"/> <display value="Aventis Behring L.L.C."/> <designation> <language value="nl"/> <value value="Aventis Behring L.L.C."/> </designation> </concept> <concept> <code value="AVI"/> <display value="Aviron"/> <designation> <language value="nl"/> <value value="Aviron"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="[Inactive--use BAH]"/> </extension> <code value="BA"/> <display value="Baxter Healthcare Corporation"/> <designation> <language value="nl"/> <value value="Baxter Healthcare Corporation"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="(includes Hyland Immuno, Immuno International AG, and North American Vaccine, Inc.)"/> </extension> <code value="BAH"/> <display value="Baxter Healthcare Corporation"/> <designation> <language value="nl"/> <value value="Baxter Healthcare Corporation"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="(includes Miles, Inc. and Cutter Laboratories)"/> </extension> <code value="BAY"/> <display value="Bayer Corporation"/> <designation> <language value="nl"/> <value value="Bayer Corporation"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="[Inactive--use BPC]"/> </extension> <code value="BP"/> <display value="Berna Products"/> <designation> <language value="nl"/> <value value="Berna Products"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="(includes Swiss Serum and Vaccine Institute Berne)"/> </extension> <code value="BPC"/> <display value="Berna Products Corporation"/> <designation> <language value="nl"/> <value value="Berna Products Corporation"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="[Inactive--use AVB]"/> </extension> <code value="CEN"/> <display value="Centeon L.L.C."/> <designation> <language value="nl"/> <value value="Centeon L.L.C."/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="[Inactive--use NOV] includes PowderJect Pharmaceuticals, Celltech Medeva Vaccines and Evans Medical Limited CDC Changes made on: July 14, 2006"/> </extension> <code value="CHI"/> <display value="Chiron Corporation"/> <designation> <language value="nl"/> <value value="Chiron Corporation"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="[Inactive--use NOV] CDC Changes made on: July 14, 2006"/> </extension> <code value="CMP"/> <display value="Celltech Medeva Pharmaceuticals"/> <designation> <language value="nl"/> <value value="Celltech Medeva Pharmaceuticals"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="CDC Changes made on: Feb. 28, 2006"/> </extension> <code value="CNJ"/> <display value="Cangene Corporation"/> <designation> <language value="nl"/> <value value="Cangene Corporation"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="[Inactive--use PMC]"/> </extension> <code value="CON"/> <display value="Connaught"/> <designation> <language value="nl"/> <value value="Connaught"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="CDC Changes made on: July 14, 2006"/> </extension> <code value="DVC"/> <display value="DynPort Vaccine Company, LLC"/> <designation> <language value="nl"/> <value value="DynPort Vaccine Company, LLC"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="[Inactive--use NOV] CDC Changes made on: July 14, 2006"/> </extension> <code value="EVN"/> <display value="Evans Medical Limited"/> <designation> <language value="nl"/> <value value="Evans Medical Limited"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="CDC Changes made on: July 14, 2006"/> </extension> <code value="GEO"/> <display value="GeoVax Labs, Inc."/> <designation> <language value="nl"/> <value value="GeoVax Labs, Inc."/> </designation> </concept> <concept> <code value="GRE"/> <display value="Greer Laboratories, Inc."/> <designation> <language value="nl"/> <value value="Greer Laboratories, Inc."/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="[Inactive--use BAH]"/> </extension> <code value="IAG"/> <display value="Immuno International AG"/> <designation> <language value="nl"/> <value value="Immuno International AG"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="[Inactive--use PMC]"/> </extension> <code value="IM"/> <display value="Merieux"/> <designation> <language value="nl"/> <value value="Merieux"/> </designation> </concept> <concept> <code value="IUS"/> <display value="Immuno-U.S., Inc."/> <designation> <language value="nl"/> <value value="Immuno-U.S., Inc."/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="(BIKEN)"/> </extension> <code value="JPN"/> <display value="The Research Foundation for Microbial Diseases of Osaka University"/> <designation> <language value="nl"/> <value value="The Research Foundation for Microbial Diseases of Osaka University"/> </designation> </concept> <concept> <code value="KGC"/> <display value="Korea Green Cross Corporation"/> <designation> <language value="nl"/> <value value="Korea Green Cross Corporation"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="[Inactive--use WAL]"/> </extension> <code value="LED"/> <display value="Lederle"/> <designation> <language value="nl"/> <value value="Lederle"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="[Inactive--use MBL]"/> </extension> <code value="MA"/> <display value="Massachusetts Public Health Biologic Laboratories"/> <designation> <language value="nl"/> <value value="Massachusetts Public Health Biologic Laboratories"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="(formerly Massachusetts Public Health Biologic Laboratories)"/> </extension> <code value="MBL"/> <display value="Massachusetts Biologic Laboratories"/> <designation> <language value="nl"/> <value value="Massachusetts Biologic Laboratories"/> </designation> </concept> <concept> <code value="MED"/> <display value="MedImmune, Inc."/> <designation> <language value="nl"/> <value value="MedImmune, Inc."/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="[Inactive--use BAY]"/> </extension> <code value="MIL"/> <display value="Miles"/> <designation> <language value="nl"/> <value value="Miles"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="(formerly Michigan Biologic Products Institute)"/> </extension> <code value="MIP"/> <display value="Bioport Corporation"/> <designation> <language value="nl"/> <value value="Bioport Corporation"/> </designation> </concept> <concept> <code value="MSD"/> <display value="Merck & Co., Inc."/> <designation> <language value="nl"/> <value value="Merck & Co., Inc."/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="(formerly North American Biologicals, Inc.)"/> </extension> <code value="NAB"/> <display value="NABI"/> <designation> <language value="nl"/> <value value="NABI"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="[Inactive--use BAH]"/> </extension> <code value="NAV"/> <display value="North American Vaccine, Inc."/> <designation> <language value="nl"/> <value value="North American Vaccine, Inc."/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="(includes Chiron, PowderJect Pharmaceuticals, Celltech Medeva Vaccines and Evans Limited, Ciba-Geigy Limited and Sandoz Limited)"/> </extension> <code value="NOV"/> <display value="Novartis Pharmaceutical Corporation"/> <designation> <language value="nl"/> <value value="Novartis Pharmaceutical Corporation"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="CDC Changes made on: July 14, 2006"/> </extension> <code value="NVX"/> <display value="Novavax, Inc."/> <designation> <language value="nl"/> <value value="Novavax, Inc."/> </designation> </concept> <concept> <code value="NYB"/> <display value="New York Blood Center"/> <designation> <language value="nl"/> <value value="New York Blood Center"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="(formerly Ortho Diagnostic Systems, Inc.)"/> </extension> <code value="ORT"/> <display value="Ortho-Clinical Diagnostics"/> <designation> <language value="nl"/> <value value="Ortho-Clinical Diagnostics"/> </designation> </concept> <concept> <code value="OTC"/> <display value="Organon Teknika Corporation"/> <designation> <language value="nl"/> <value value="Organon Teknika Corporation"/> </designation> </concept> <concept> <code value="OTH"/> <display value="Other manufacturer"/> <designation> <language value="nl"/> <value value="Andere fabrikant"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="(formerly Parke-Davis)"/> </extension> <code value="PD"/> <display value="Parkedale Pharmaceuticals"/> <designation> <language value="nl"/> <value value="Parkedale Pharmaceuticals"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="(formerly Aventis Pasteur, Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux) CDC Changes made on: Feb. 28, 2006"/> </extension> <code value="PMC"/> <display value="sanofi pasteur"/> <designation> <language value="nl"/> <value value="sanofi pasteur"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="[Inactive--use WAL]"/> </extension> <code value="PRX"/> <display value="Praxis Biologics"/> <designation> <language value="nl"/> <value value="Praxis Biologics"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="(includes Celltech Medeva Vaccines and Evans Medical Limited) [Inactive--use NOV] CDC Changes made on: July 14, 2006"/> </extension> <code value="PWJ"/> <display value="PowderJect Pharmaceuticals"/> <designation> <language value="nl"/> <value value="PowderJect Pharmaceuticals"/> </designation> </concept> <concept> <code value="SCL"/> <display value="Sclavo, Inc."/> <designation> <language value="nl"/> <value value="Sclavo, Inc."/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="[Inactive--use BPC]"/> </extension> <code value="SI"/> <display value="Swiss Serum and Vaccine Inst."/> <designation> <language value="nl"/> <value value="Swiss Serum and Vaccine Inst."/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="(formerly SmithKline Beecham; includes SmithKline Beecham and Glaxo Welcome)"/> </extension> <code value="SKB"/> <display value="GlaxoSmithKline"/> <designation> <language value="nl"/> <value value="GlaxoSmithKline"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="CDC Changes made on: July 14, 2006"/> </extension> <code value="SOL"/> <display value="Solvay Pharmaceuticals"/> <designation> <language value="nl"/> <value value="Solvay, Pharmaceuticals"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="(includes Bayer Biologicals) CDC Changes made on: Feb. 28, 2006"/> </extension> <code value="TAL"/> <display value="Talecris Biotherapeutics"/> <designation> <language value="nl"/> <value value="Talecris Biotherapeutics"/> </designation> </concept> <concept> <code value="UNK"/> <display value="Unknown manufacturer"/> <designation> <language value="nl"/> <value value="Unknown manufacturer"/> </designation> </concept> <concept> <code value="USA"/> <display value="United States Army Medical Research and Material Command"/> <designation> <language value="nl"/> <value value="United States Army Medical Research and Material Command"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="CDC Changes made on: July 14, 2006"/> </extension> <code value="VXG"/> <display value="VaxGen"/> <designation> <language value="nl"/> <value value="VaxGen"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="[Inactive--use WAL]"/> </extension> <code value="WA"/> <display value="Wyeth-Ayerst"/> <designation> <language value="nl"/> <value value="Wyeth-Ayerst"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="(includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics)"/> </extension> <code value="WAL"/> <display value="Wyeth-Ayerst"/> <designation> <language value="nl"/> <value value="Wyeth-Ayerst"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="(includes Aventis Behring and Armour Pharmaceutical Company) CDC Changes made on: Feb. 28, 2006"/> </extension> <code value="ZLB"/> <display value="ZLB Behring"/> <designation> <language value="nl"/> <value value="ZLB Behring"/> </designation> </concept> </CodeSystem>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.